Indian Markets Analyzed: November 25, 2025

Key Points

• Global markets are rising, boosting investor confidence.
• Indian stocks are tracking this positive trend.
• Several companies announced promising developments.
• Siemens Energy India reported strong growth and a dividend.
• Diamond Power Infrastructure secured a major contract.
• Eris Lifesciences expanded through a strategic acquisition.

Today, November 25, 2025, the Indian stock market is expected to start its trading session with a flat trend, influenced by positive signals from global markets. Specifically, overnight gains in the U.S. market, driven by renewed interest in artificial intelligence and expectations of future interest rate cuts, are helping to support the overall outlook. This is creating a positive backdrop for Indian markets.

Here’s a look at key stocks to watch. Siemens Energy India showed impressive results, growing its revenue by 27% to ₹2,646 crore and increasing its profit after tax by 31% to ₹360 crore. They’re also paying out a generous dividend – ₹4 per share!

Diamond Power Infrastructure has landed a significant contract worth over ₹276 crore from Adani Energy Solutions for supplying AL-59 Zebra Conductor for the Khavda Project. This demonstrates the company’s growing importance in infrastructure development.

Surya Roshni secured a large order for spiral pipes, showcasing demand for their products and a strategic move into this market segment. The order worth ₹105.18 crore highlights this growth.

Sunteck Realty is making a big move into the Dubai real estate market with plans for a major development project worth AED 15 billion (approximately ₹36,500 crore) over the next three years, starting with a luxury residential project in Downtown Dubai.

Dr. Reddy’s Laboratories has received approval for a biosimilar of Prolia and Xgeva, medications used to treat bone loss and cancer. This new product is likely to increase their revenue.

Pavna Industries has reached an agreement with the Government of Uttar Pradesh to set up a new project in the state. This is a key step in the company’s expansion plans.

Eris Lifesciences is expanding through a strategic acquisition of 30% of Swiss Parenterals Limited, a subsidiary of Eris. This acquisition strengthens Eris’s position in the biopharmaceutical market.

Cello World is assigning the “Cello” trademark for stationery and writing instruments on a zero-royalty basis. They anticipate generating around ₹200 crore in revenue from this brand in its first full year.

Ceigall India has received a work order from REC Power Development and Consultancy for setting up a 400/220 kV Velgaon GIS substation. This reinforces their role in electricity infrastructure.

Niraj Cement Structurals has been awarded a contract by NHIDCL for constructing a two-lane road in Nagaland. This supports their expansion and capabilities in construction projects.

Paras Defence and Space Technologies is collaborating with the Inter-University Accelerator Centre to develop indigenous MRI magnet technology, aiming for self-reliance in this sector.

HUDCO has partnered with the National Institute of Urban Affairs to develop joint programs focusing on urban infrastructure and development, aligning with national priorities.

Apollo Hospitals has opened a new healthcare facility in Pune, demonstrating continued growth and expansion within India’s healthcare sector.

Stallion India Fluorochemicals has affirmed its revenue growth guidance of 30-35% for FY26, highlighting continued momentum and strong expectations.

“Smart investors watch these companies closely to understand where opportunities lie.”